Equity Research, Broker Reports, and media content on GALAPAGOS NV

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about GALAPAGOS NV
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on GALAPAGOS NV. We currently have 0 research reports from 0 professional analysts.

Date Source Announcement
24Nov16 06:30 GNW Galapagos selected for Stoxx Europe 600 Index
22Nov16 09:00 GNW Phase 3 study with filgotinib initiated in Crohn's disease
27Oct16 09:00 GNW Robust progress in Q3 2016
27Oct16 06:30 GNW Galapagos to present progress in CF programs at NACFC 2016
12Oct16 09:00 GNW Transparency notification - FMR LLC reaches 10% threshold
29Sep16 06:30 GNW MorphoSys and Galapagos Start First-In-Patient Dosing of IL-17C Antibody MOR106 in Atopic Dermatitis
27Sep16 09:00 GNW Successful completion of regulatory consultations to progress filgotinib to Phase 3 in inflammatory bowel disease
  • Frequency of research reports


  • Research reports on


  • Providers covering